The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Oxidative stress in end-stage renal disease: an emerging threat to patient outcome
Abstract
INTRODUCTION: Patients affected by end-stage renal disease (ESRD) experience an excess of morbidity and mortality due to cardiovascular disease (CVD), which cannot be fully explained by the classical CVD risk factors. Among emerging CVD risk factors, oxidative stress is currently being given emphasis. METHODS: We achieved a consensus on key points relating to oxidative stress in ESRD patients. RESULTS: ESRD patients are subjected to enhanced oxidative stress, as a result of reduced anti-oxidant systems (vitamin C and selenium deficiency, reduced intracellular levels of vitamin E, reduced activity of the glutathione system) and increased pro-oxidant activity (advanced age, high frequency of diabetes, chronic inflammatory state, uraemic syndrome, bio-incompatibility of dialysis membranes and solutions). Oxidative stress and inflammation are deeply inter-related, as different oxidant free radicals are generated by phagocytic cells in response to inflammatory stimuli: both are related to endothelial dysfunction, as the endothelium is a source and a target of oxidants and participates in the inflammatory response. There is growing evidence, from experimental and clinical studies, that oxidative stress may be implicated in the pathogenesis of atherosclerosis and other complications of ESRD, namely dialysis-related amyloidosis, malnutrition and anaemia. Given that free radicals have very short half-lives (seconds), the clinical assessment of oxidative stress is based on the measurement of different stable oxidized compounds (such as lipid peroxidation products, advanced glycation and oxidation lipid and protein products, nucleic acid oxidation derivatives) or antibodies directed against oxidized epitopes (such as anti-oxidized low-density lipoprotein antibodies). At the same time, both enzymatic anti-oxidants (superoxide dismutase, catalase, glutathione peroxidase) and non-enzymatic anti-oxidants (glutathione, vitamin C, vitamin E, negative inflammatory proteins) can be evaluated. However, many laboratory methods assessing various oxidative stress components still have to be standardized. Moreover, it is still uncertain whether it is better measuring plasma and/or intracellular concentrations or activities of these components. The possibility of improving patient outcome by therapeutic interventions aimed at reducing oxidative stress, e.g. by vitamin C or vitamin E supplementation, currently is to the fore, but results so far have remained inconclusive. CONCLUSIONS: It is important to consider oxidative stress as a potentially important source of patient morbidity and mortality, although this knowledge is not yet immediately applicable in the clinical arena. Further well-designed, randomized controlled clinical trials with anti-oxidants (e.g. vitamin E, vitamin C, N-acetyl cysteine, L-arginine) are required to establish evidence-based recommendations for clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative stress: oxidants and antioxidants
Sies, H. (1997) · Experimental Physiology · doi:10.1113/expphysiol.1997.sp004024 · Cited by 4,566
Stephens, N. G., Parsons, A., Brown, M. J., Schofield, P. M., Kelly, F., Cheeseman, K., & Mitchinson, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90866-1 · Cited by 2,148
Advanced oxidation protein products as a novel marker of oxidative stress in uremia
Witko-Sarsat, V., Friedlander, M., Capeillère-Blandin, C., Nguyen-Khoa, T., Nguyen, A. T., Zingraff, J., Jungers, P., & Descamps-Latscha, B. (1996) · Kidney International · doi:10.1038/ki.1996.186 · Cited by 1,999
Brown, B. G., Zhao, X.-Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011090 · Cited by 1,979
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Münzel, T. (2001) · Circulation · doi:10.1161/hc4601.099485 · Cited by 1,961
Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087
Self-citationBoaz, M., Smetana, S., Weinstein, T., Matas, Z., Gafter, U., Iaina, A., Knecht, A., Weissgarten, Y., Brunner, D., Fainaru, M., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02783-5 · Cited by 1,025
Oxy-Radicals and Related Species: Their Formation, Lifetimes, and Reactions
Pryor, W. A. (1986) · Annual Review of Physiology · doi:10.1146/annurev.ph.48.030186.003301 · Cited by 998
Levey, A., Beto, J., Coronado, B., Eknoyan, G., Foley, R., Kasiske, B., Klag, M., Mailloux, L., Manske, C., Meyer, K., et al. (1998) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(98)70145-3 · Cited by 946
Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease
Zhang, R. (2001) · JAMA · doi:10.1001/jama.286.17.2136 · Cited by 918
Advanced Glycosylation End Products in Patients with Diabetic Nephropathy
Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E. A., Cerami, A., & Vlassara, H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109193251202 · Cited by 918
Witko-Sarsat, V., Friedlander, M., Khoa, T. N., Capeillère-Blandin, C., Nguyen, A. T., Canteloup, S., Dayer, J.-M., Jungers, P., Drüeke, T., & Descamps-Latscha, B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2524 · Cited by 878
Laursen, J. B., Somers, M., Kurz, S., McCann, L., Warnholtz, A., Freeman, B. A., Tarpey, M., Fukai, T., & Harrison, D. G. (2001) · Circulation · doi:10.1161/01.cir.103.9.1282 · Cited by 721 · cited 1×
“Oxidation of tetrahydrobiopterin has relevant consequences because in this particular situation, NO synthase functions as an oxidizing enzyme itself and generates superoxide anion, thus amplifying oxidative stress [45].”
BackgroundSchleicher, E. D., Wagner, E., & Nerlich, A. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119180 · Cited by 714
Torzewski, M., Rist, C., Mortensen, R. F., Zwaka, T. P., Bienek, M., Waltenberger, J., Koenig, W., Schmitz, G., Hombach, V., & Torzewski, J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2094 · Cited by 581
Jiang, Q., Elson-Schwab, I., Courtemanche, C., & Ames, B. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200357097 · Cited by 523
Miyata, T., van Ypersele de Strihou, C., Kurokawa, K., & Baynes, J. W. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00302.x · Cited by 518
Tepel, M., van der Giet, M., Statz, M., Jankowski, J., & Zidek, W. (2003) · Circulation · doi:10.1161/01.cir.0000050628.11305.30 · Cited by 377
KIELSTEIN, J. T., BÖGER, R. H., BODE-BÖGER, S. M., SCHÄFFER, J., BARBEY, M., KOCH, K. M., & FRÖLICH, J. C. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v103594 · Cited by 361
Oral α-Tocopherol Supplements Decrease Plasma γ-Tocopherol Levels in Humans
Handelman, G. J., Machlin, L. J., Fitch, K., Weiter, J. J., & Dratz, E. A. (1985) · The Journal of Nutrition · doi:10.1093/jn/115.6.807 · Cited by 260
Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment
Nguyen‐Khoa, T., Massy, Z. A., De Bandt, J. P., Kebede, M., Salama, L., Lambrey, G., Witko‐Sarsat, V., Drüeke, T. B., Lacour, B., & Thévenin, M. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.2.335 · Cited by 252
Hemodialysis Impairs Endothelial Function via Oxidative Stress: Effects of Vitamin E–Coated Dialyzer
Miyazaki, H., Matsuoka, H., Itabe, H., Usui, M., Ueda, S., Okuda, S., & Imaizumi, T. (2000) · Circulation · doi:10.1161/01.cir.101.9.1002 · Cited by 231
Nitric Oxide Production Is Reduced in Patients With Chronic Renal Failure
Wever, R., Boer, P., Hijmering, M., Stroes, E., Verhaar, M., Kastelein, J., Versluis, K., Lagerwerf, F., van Rijn, H., Koomans, H., et al. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.5.1168 · Cited by 219
Elevated plasma F2-isoprostanes in patients on long-term hemodialysis
Handelman, G. J., Walter, M. F., Adhikarla, R., Gross, J., Dallal, G. E., Levin, N. W., & Blumberg, J. B. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590051960.x · Cited by 208
Infection and Inflammation Induce LDL Oxidation In Vivo
Memon, R. A., Staprans, I., Noor, M., Holleran, W. M., Uchida, Y., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1536 · Cited by 207
Advanced glycation end products and mortality in hemodialysis patients
Schwedler, S. B., Metzger, T., Schinzel, R., & Wanner, C. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00423.x · Cited by 195
Self-citationMezzano, D., Pais, E. O., Aranda, E., Panes, O., Downey, P., Ortiz, M., Tagle, R., González, F., Quiroga, T., Caceres, M. S., et al. (2001) · Kidney International · doi:10.1016/s0085-2538(15)48065-2 · Cited by 189
Chronic Renal Failure — A Vasculopathic State
Luke, R. G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809173391211 · Cited by 184
Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis
Boaz, M., Matas, Z., Biro, A., Katzir, Z., Green, M., Fainaru, M., & Smetana, S. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00613.x · Cited by 174
Dialysis‐Induced Oxidative Stress: Biological Aspects, Clinical Consequences, and Therapy
Descamps‐Latscha, B., Drüeke, T., & Witko‐Sarsat, V. (2001) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2001.00052.x · Cited by 162
Cardiovascular risk in uraemic patients—is it fully explained by classical risk factors?
Zoccali, C. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.4.454 · Cited by 162
Self-citationImbalance of Oxidants and Antioxidants in Haemodialysis Patients
Canaud, B., Cristol, J., Morena-Carrere, M., Leray‐Moragues, H., Bosc, J., & Vaussenat, F. (1999) · Blood Purification · doi:10.1159/000014381 · Cited by 155
Self-citationMechanisms for the formation of glycoxidation products in end-stage renal disease
Weiss, M. F., Erhard, P., Kader-Attia, F. A., Wu, Y. C., DeOreo, P. B., Araki, A., Glomb, M. A., & Monnier, V. M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00117.x · Cited by 155
Brown, B. G., Zhao-Q, X., Chait, A., & Fisher, L. D. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00657-8 · Cited by 144
Pecoits‐Filho, R., Stenvinkel, P., Marchlewska, A., Heimbürger, O., Barany, P. F., Hoff, C. M., Holmes, C. J., Suliman, M., Lindholm, B., Schalling, M., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s84.32.x · Cited by 126
Self-citationTarng, D., Huang, T., Wei, Y., Liu, T., Chen, H.-W., Chen, T. W., & Yang, W.-C. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.19086 · Cited by 125
Islam, K. N., O’Byrne, D., Devaraj, S., Palmer, B. F., Grundy, S. M., & Jialal, I. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00410-4 · Cited by 121
Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter
Galli, F., Rovidati, S., Chiarantini, L., Campus, G., Canestrari, F., & BUONCRISTIANI, U. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00021.x · Cited by 119
Cardiovascular disease in chronic renal failure: the challenge continues
Locatelli, F., Marcelli, D., Conte, F., DʼAmico, M., Vecchio, L. D., Limido, A., Malberti, F., & Spotti, D. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.suppl_5.69 · Cited by 117
Self-citationSchwedler, S. B., Schinzel, R., Vaith, P., & Wanner, C. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.59780032.x · Cited by 100
Self-citationAbu‐Soud, H. M., Khassawneh, M. Y., Sohn, J., Murray, P. A., Haxhiu, M. A., & Hazen, S. L. (2001) · Biochemistry · doi:10.1021/bi011206v · Cited by 90
Mezzano, D., Pais, E. O., Aranda, E., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00998.x · Cited by 90
Fp, B., & Selwood, N. H. (1992) · PubMed · Cited by 57
Evaluation of Oxidant Stress in Dialysis Patients
Handelman, G. J. (2000) · Blood Purification · doi:10.1159/000014460 · Cited by 53
Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients
Nguyen‐Khoa, T., Massy, Z. A., Witko‐Sarsat, V., Thévenin, M., Touam, M., Lambrey, G., Lacour, B., Drüeke, T. B., & Descamps‐Latscha, B. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00565.x · Cited by 46
Zoccali, C., Mallamaci, F., Asahia, K., Benedetto, F. A., Tripepi, G. L., Tripepi, R., Nicocia, G., Buemi, M., & Miyata, T. (2001) · PubMed · Cited by 35
Self-citation
Cited by
The role of antioxidants in the chemistry of oxidative stress: A review
Pisoschi, A. M., & Pop, A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.040 · Cited by 2,806
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
(2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.01.019 · Cited by 1,427
Oxidative Stress in Human Pathology and Aging: Molecular Mechanisms and Perspectives
Hajam, Y. A., Rani, R., Ganie, S. Y., Sheikh, T. A., Javaid, D., Qadri, S. S., Pramodh, S., Alsulimani, A., Alkhanani, M. F., Harakeh, S., et al. (2022) · Cells · doi:10.3390/cells11030552 · Cited by 915
Oxidative stress in chronic kidney disease
Daenen, K., Andries, A., Mekahli, D., Van Schepdael, A., Jouret, F., & Bammens, B. (2019) · Pediatric Nephrology · doi:10.1007/s00467-018-4005-4 · Cited by 882
Immune cell dysfunction and inflammation in end-stage renal disease
Betjes, M. G. H. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.44 · Cited by 542
Metadata
- Authors
- Locatelli, F., Canaud, B., Eckardt, K.-U., Stenvinkel, P., Wanner, C., & Zoccali, C.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-07-01
- Volume
- 18
- Issue
- 7
- Pages
- 1272-1280
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2136128927
- Cited by
- 758
- References
- 47
- FWCI
- 17.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.